Page 16 - Polypeptide Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Feb 19, 2021 By Alex Keown PICI – Bristol Myers Squibb veteran Ute Dugan was named Senior Vice President of Clinical Research at the Parker Institute for Cancer Immunotherapy (PICI). She will oversee PICI’s clinical development, regulatory affairs and translational medicine efforts, with a focus on overcoming immunotherapy resistance and advancing novel breakthrough treatment combinations. At BMS, she was head of Worldwide Oncology External Medical Affairs, where she created research collaboration models to advance immune-oncology treatments together with partners in ac...

Read more about PolyPeptide Group names new CEO before likely Swiss IPO during 2021 on Business Standard. Raymond De Vre, a Belgian who previously worked at Indian contract manufacturer Dr. Reddy's Laboratories as global head of biologics, will join PolyPeptide Group as CEO-elect in April

Advanced Peptide Synthesis Program Uses Predictive Modeling and Simulation Tools to Shorten Peptide Process Development The field of Solid Phase Peptide Synthesis (SPPS) has boomed over the last few decades. But many companies are still relying on procedures used in the laboratory to achieve large-scale production. This has proven to be inefficient and not cost-effective. Not surprisingly, the overall quest to produce high-quality peptides at lower costs while meeting customers’ expectations for issues like cutting solvent consumption (and reducing environmental impact) without affecting th...